News | November 01, 2023
Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
With the establishment of five different precious metals alloy powder production methods
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
The companies plan to start a pivotal Phase 3 trial in the coming months
Subscribe To Our Newsletter & Stay Updated
